Generally, patients have a favorable prognosis after discontinuation of the offending drug, as 90% recover. Mortality risk can be predicted through “Hy’s law,” which includes the following criteria that are associated with a poorer prognosis: ALT/AST more than 3 times ULN, total bilirubin up to 2 times ULN in the absence of obstruction, and no other explanation of the mentioned laboratory values.